Morphf mutants of Rous sarcoma virus: nucleotide sequencing analysis suggests that a class of morphf mutants was

Journal of Virology
|June 1, 1987
PubMed

Insights

Aberrant RNA splicing caused deletions in Rous sarcoma virus (RSV) src gene, leading to fusiform cell shape. A second mutation in tsST529 conferred temperature-sensitive transformation, revealing src gene

Area of Science:

  • Molecular virology
  • Cancer research
  • Genetics

Background:

  • Rous sarcoma virus (RSV) causes cell transformation and tumors.
  • The v-src gene product, p60v-src, is a tyrosine kinase critical for transformation.
  • Understanding mutations in v-src is key to deciphering transformation mechanisms.

Purpose of the Study:

  • To investigate the molecular basis of the fusiform cell phenotype in RSV mutants WO101, WO201, and tsST529.
  • To determine the role of specific v-src gene alterations in viral transformation.
  • To elucidate the mechanism of mutation generation in viral oncogenes.

Main Methods:

  • Molecular cloning and DNA sequencing of RSV mutant genomes.
  • RNA analysis using S1 mapping to identify splicing events.
  • Analysis of protein alterations (p60v-src) and their impact on cell morphology.

Main Results:

  • Mutants WO101 and WO201 possess an in-frame deletion in the v-src gene (amino acids 116-140), likely due to aberrant RNA splicing.
  • This deletion involves splice sites and a branchpoint acceptor, suggesting a novel mutation pathway.
  • Mutant tsST529 contains the same deletion plus a point mutation (E93K), causing temperature-sensitive transformation.

Conclusions:

  • Aberrant RNA splicing can generate stable mutations in viral oncogenes, impacting cell transformation.
  • The N-terminal region of the v-src gene encodes a structural domain crucial for regulating cell morphology during RSV infection.
  • Specific mutations within this domain, like the deletion and the tsST529 point mutation, differentially affect p60v-src function and transformation.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...